EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Androgen deprivation–mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion

Fen Ma, Sen Chen, Luigi Cecchi, Betul Ersoy-Fazlioglu, Joshua W Russo, Seiji Arai, Seifeldin Awad, Carla Calagua, Fang Xie, Larysa Poluben, Olga Voznesensky, Anson T Ku und 9 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci192368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Fen Ma und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Proto-Oncogene Proteins c-akt, Oncogene Proteins, Fusion, Serine Endopeptidases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProto-Oncogene Proteins c-aktOncogene Proteins, FusionSerine EndopeptidasesMaleAnimalsHumansMiceTranscriptional Regulator ERGCell Line, TumorReceptors, AndrogenAndrogensPTEN Phosphohydrolase

Stichwörter der Autor:innen

Cell biologyInositol phosphatesOncogenesOncologyProstate cancer

Substanzen

Proto-Oncogene Proteins c-aktOncogene Proteins, FusionTMPRSS2-ERG fusion protein, humanTranscriptional Regulator ERGTMPRSS2 protein, humanSerine EndopeptidasesReceptors, AndrogenERG protein, humanAndrogensPTEN Phosphohydrolase

Autor:innen und Institutionen

  • Department of Medicine and Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Department of Urology, Gunma University Hospital, Maebashi, Gunma, Japan.
  • Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Center for Personalized Cancer Therapy and Department of Biology, University of Massachusetts Boston, Boston, Massachusetts, USA.
  • Department of Pathology and Cancer Center, Beth Israel Deaconess Medical Center, and.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • National Cancer Institute
  • DOD Prostate Cancer Research Program
  • Prostate Cancer Foundation

Zitieren

APA

Ma, F., Chen, S., Cecchi, L., Ersoy-Fazlioglu, B., Russo, J. W., Arai, S., Awad, S., Calagua, C., Xie, F., Poluben, L., Voznesensky, O., Ku, A. T., Karzai, F., Cai, C., Einstein, D. J., Ye, H., Yuan, X., Toker, A., Taplin, M. E., …, & Balk, S. P. (2025). Androgen deprivation–mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion. Journal of Clinical Investigation. https://doi.org/10.1172/jci192368

Vancouver

Ma F, Chen S, Cecchi L, Ersoy-Fazlioglu B, Russo JW, Arai S, et al. Androgen deprivation–mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion. Journal of Clinical Investigation. 2025. doi:10.1172/jci192368

BibTeX
@article{Ma2025,
  author = {Ma, Fen and Chen, Sen and Cecchi, Luigi and Ersoy-Fazlioglu, Betul and Russo, Joshua W and Arai, Seiji and Awad, Seifeldin and Calagua, Carla and Xie, Fang and Poluben, Larysa and Voznesensky, Olga and Ku, Anson T and Karzai, Fatima and Cai, Changmeng and Einstein, David J and Ye, Huihui and Yuan, Xin and Toker, Alex and Taplin, Mary-Ellen and Sowalsky, Adam G and Balk, Steven P},
  title = {Androgen deprivation–mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci192368}
}
Kostenlos starten →